div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030fdocumentsinreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030fdocumentsinreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030fdocumentsinreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030fdocumentsinreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in...